(0.5M)*
**
***
|
|
|
|
(0.5M) |
Dodge-Khatami A*, Tsang VT**, Roebuck DJ***, Elliott MJ**. Management of congenital tracheal stenosis: a multidisciplinary approach. Images Paediatr Cardiol 2000;2:29-39 |
|
*
|
Senior Surgical Registrar, Cardiothoracic Unit, Great Ormond Street, London |
|
**
|
Consultant Paediatric Cardiothoracic Surgeon, Cardiothoracic Unit, Great Ormond Street, London |
|
***
|
Consultant Interventional Cardiologist, Cardiothoracic Unit, Great Ormond Street, London |
| MeSH | ||
| Congenital tracheal stenosis | Multidisciplinary management | Heart defects, congenital |
| Prognosis |
Article
Introduction
Long-segment congenital tracheal stenosis associated with complete
tracheal rings can cause life-threatening respiratory distress in neonates
and infants. Surgery usually represents the ultimate therapy for this anomaly,
particularly because of associated vascular and cardiac lesions. Initial
emergent control of the airway is required with intubation and mechanical
ventilation when possible, while planning a definitive surgical correction.
If adequate oxygenation and ventilation cannot be achieved before operative
repair, extracorporeal membrane oxygenation (ECMO) or intraluminal tracheal
stenting may be life-saving procedures as a bridge towards surgery. Post-operative
therapy may involve prolonged ventilation and follow-up of the airway with
bronchoscopy, during which granulation tissue removal and stenting may
be performed as required. As these various treatment modalities imply,
the care of the patient with congenital tracheal stenosis involves an initial
emergent life-saving procedure, as well as a long-term strategy incorporating
nursing, medical, surgical and interventional radiology teams. This case
illustrates how these rare but demanding patients may be best cared for
through combined multidisciplinary dedication, and the need for close post-operative
follow-up.
Case
Baby CF was transferred emergently to our institution following elective
caesarean delivery for failure to progress. At birth, he was in severe
respiratory distress with no breath sounds entering either lung field and
had decompensated respiratory acidosis. Endotracheal (ET) intubation was
achieved with great difficulty with a size 3.0 mm tube before transfer
from the outside hospital, although this was the expected size tube for
the patient's weight. After failing conventional and then oscillatory mechanical
ventilation, he was placed on veno-arterial ECMO at one day of life. Chest
x-ray showed a tiny central airway shadow and bilateral whitening of the
peripheral lung fields (Fig 1).
| A bronchogram confirmed the suspicion of long-segment tracheal stenosis (Fig 2). Echocardiography was performed and showed no intracardiac abnormality. After improvement of his peripheral perfusion, the lung fields gradually cleared following ECMO and continuous veno-venous hemofiltration (CVVH). He achieved a satisfactory fluid balance and was deemed suitable for tracheal repair. |
 |
He underwent multiple bronchoscopies revealing persistent troublesome
granulation tissue at the lower end of the pericardial patch repair. These
granulations required repeat debridement and/or laser vaporization. After
7 weeks of continuous mechanical ventilation and repeat bronchoscopies,
he underwent one further laser bronchoscopy of granulation tissue and balloon
dilation of the distal trachea. His condition improved dramatically with
marked reduction in ventilatory requirements (lowered mean airway pressures,
FIO2 and rate), and it was decided to apply a more ‘permanent’ intraluminal
dilating procedure. Thus, a balloon-expandable intraluminal metallic Palmaz
endovascular stent (8-12mm diameter, 30mm length) was inserted into the
trachea under fluoroscopic guidance (Fig. 3). This procedure was uneventful.
Following stenting, he was extubated to a nasal CPAP prong after 3 days.
The CPAP was weaned over 2 weeks and he tolerated decreasing oxygen to
room air.
| Despite a satisfactory clinical condition, control bronchoscopy performed 3 weeks post stent placement revealed recurrence of granulation tissue, which was lasered. Two days later, he underwent balloon dilation of his stent (Figs. 4-6) and residual granulation tissue (balloon size 8). Finally, after two and a half months of hospitalization, he was breathing comfortably on room air, was afebrile, had a clear chest auscultation and x-ray image with well expanded lungs beyond a well-positioned Palmaz stent (Fig. 7). |
 |
 |
 |
| One week after discharge, he was readmitted to the hospital for cyanosis and respiratory collapse requiring emergent intubation. Bronchoscopy disclosed a large protruding polyp of granulation tissue at the carina, which was vaporized, and an otherwise patent stent. Subsequently, he was rapidly weaned and extubated with good recovery. Obvious close follow-up with bronchoscopy is planned since this last admission (Fig. 8). |
 |
The clinical presentation may vary from stridulous cough and recurrent lower respiratory tract infections to acute and life-threatening respiratory insufficiency. Initial diagnostic workup includes a chest x-ray, and a barium swallow is performed to disclose an associated PA sling, seen as an anterior indentation on the oesophagus, if the patient is stable enough. A spiral CT scan of the chest will allow for reconstructive images of the trachea and assess the degree and length of tracheal stenosis, and will also document the PA sling, if present. Micro-laryngo-brochoscopy (MLB) can document the extent of tracheal disease. A bronchogram may reveal distal tracheo-bronchomalacia and is very useful when an MLB cannot reach the distal involvement of the anomaly. In order to reduce the occurrence of reactive airway disease, we use iotrolan (240 mg/ml) as a contrast agent. Finally, given the high prevalence of associated intracardiac anomalies, an echocardiogram should complete the preoperative assessment. Although our preoperative echocardiogram failed to pick up the PA sling, an echocardiogram is an accurate way of diagnosing a PA sling.
Non-operative management carries a dismal survival, with mortality ranging from 17-75%.4 Nonetheless, temporary measures include ventilation with helium-oxygen, avoidance of a tracheostomy, and sometimes emergency endotracheal stenting or ECMO as a life-saving bridge to surgery.4
Classically, surgery represents the ultimate form of treatment for this anomaly, and techniques of repair have evolved over time. Ultimately, it is the length of the diseased trachea which dictates the type of reconstruction. Primary reconstruction with end-to-end anastomosis is possible with short segment stenosis,5 but longer narrowing of the trachea involves various autologous or heterologous materials to bridge the defect. Bryant et al6 introduced the pericardial patch tracheoplasty technique, modified by Idriss7 using cardiopulmonary bypass (CPB) in 1984. Advantages of this graft material include the ready availability of pericardium, an airtight repair, the absence of rejection from an autologous tissue, a low metabolic rate requiring minimal blood supply and hence rapid healing and resistance to infection.8 Systematic covering with the specialised ciliated respiratory epithelium occurs by migration of adjacent tracheal cells.8
Tsang et al9 described the slide tracheoplasty technique in 1989, involving transection and spatulation of the proximal and distal ends through the stenosed area, with anastomosis of the two spliced extremities. Various other autologous graft materials have been used in conjunction with pericardium or alone, such as periosteum and costal cartilage.10,11 More recently, tracheal reconstruction has been performed using cryopreserved scapular allografts,12 cadaveric tracheal homografts3 and cryopreserved tracheal allografts.12,13 To enhance further the effect of cryopreservation by reducing allogenicity and hence rejection of these materials, some groups have attempted high dose irradiation14 and photodynamic therapy15 of these grafts.
The latest technique, described by Backer et al, involves the use of a free tracheal autograft, with or without pericardium.16 The autograft is fashioned by tailoring the portion of stenosed trachea that would otherwise be discarded, and is used as an anterior patch. Theoretical advantages of this technique include the use of living autologous tissue already lined with respiratory epithelium, and autograft rigidity requiring less stenting by the ET tube, hence potentially reducing intubation times as compared to pericardium. The potential for growth and technical facility are other attractive points of this operation.16 Operative mortality of all types of tracheal reconstruction is low, varying between 0 9,10 - 17%,3,17 and 5 year survival of up to 84% is reported.17
The main concern with these patients is the significant morbidity, as demonstrated by their prolonged intubation times, intensive care stay, inhospital stay, and their need for very close follow-up requiring multiple bronchoscopies, stenting and ultimately reoperation. The common denominator of all postoperative morbidity is the formation of excessive granulation tissue at the repair site, i.e. the anastomotic line between the native trachea and graft materials. The protruding tissue causes various degrees of airway obstruction, failure to clear secretions, atelectasis and respiratory distress. In view of this frequent complication, or rather natural history of post-operative tracheal healing, the mainstay of follow-up is bronchoscopy. This may be either flexible for diagnostic and documentary purposes, or rigid for therapeutic granulation tissue debridement 16 and laser vaporization to free the airway.
All grafts may get infected, necrose or dehisce, with a resultant potential for air leak and mediastinal emphysema requiring reoperation. Indications for reoperation include requirement for frequent bronchoscopic dilations, reintubation for respiratory distress and failure to wean from mechanical ventilation.18 The reconstructive technique in reoperation often involves repeat use of pericardium if any is still available, or autologous cartilage grafts.18 The incidence of reoperation after pericardial patch repair is as high as 29%,18 but is achieved with low mortality.
Intraluminal stents have gained recent popularity in the management of congenital tracheal stenosis, either preoperatively as a life-saving bridge to surgical reconstruction, or postoperatively in the event of a failed tracheoplasty procedure.19 Various types of stents exist, including the Dumon silastic stent and the metallic Palmaz stent. Dumon stents are more frequently used in the setting of tracheal neoplasm or corrosive strictures, mold the preexisting tracheal form, are readily removable, but cannot be dilated. They have a continuous wall which does not allow cross-ventilation into branch bronchi. More commonly employed are the balloon-expandable metallic wire Palmaz stents. They are dilatable up to a certain degree and have a meshwork which allows ventilation across them into smaller branching bronchi. Disadvantages include incorporation into the tracheal wall after reepithelialization and extreme difficulty in removal.19 Despite initial satisfactory enlargement of the airway, granulation tissue does develop and protrudes through the stent meshwork into the lumen. This may be managed by repeat ballooning which serves to compress the bulging granulations against the tracheal wall. Further dilatation of the stent is possible. Intraluminal stents represent a useful addition to our options, but their long-term role remains to be determined. Absorbable stents are currently under trial and may prove a valuable future asset.
Current research is being undertaken on improvements in tracheal healing, more specifically aimed at the reduction in granulation tissue formation, which universally complicates the repair anastomotic site. Vascular endothelial growth factor (VEGF) is an experimental protein which is implicated in wound healing,20 is angiogenic,20 increases vascular permeability, stimulates nitric oxide formation by the endothelium and hence vasodilation in the setting of tissue hypoxia and ischemia.20,21,22 In a rabbit model of tracheal reconstruction using tracheal autografts, pretreated with topical VEGF, autograft healing was shown to be enhanced.23 Topical VEGF reduced granulation tissue formation, induced less inflammation of the free tracheal autograft, minimized anastomotic fibrosis and hence airway obstruction.23 The future will also involve tissue engineering to grow trachea from the patients' own cell lines.
Conclusions
Congenital tracheal stenosis from complete tracheal rings presents
a rare but very challenging group of patients. Treatment requires a multidisciplinary
approach, with close coordination and collaboration amongst the various
teams. Non-operative therapy carries a high mortality, but initial stabilization
by agressive medical management, intraluminal stenting or ECMO may buy
enough time to allow a full diagnostic assessment prior to surgery.
Surgical repair represents the mainstay of therapy and is achieved with low mortality, with initial good anatomical and functional results. However, morbidity is substantial and recurrent difficulties with the airway remain a constant threat. Besides the prolonged hospital stay, outpatient and home care place the families of these patients under considerable stress. Thus, the initial care ‘contract’ with the involved families should be explicit about the degree of uncertainty. The long-term quality of life of these patients is as yet unknown, and the degree and intensity of morbidity will be better indicators of outcome than simple mortality figures.
Close follow-up with bronchoscopy is mandatory and interventional procedures such as granulation tissue debridement, vaporization, balloon dilation or intraluminal stenting should be available and considered as required. "Virtual bronchoscopy" may also be obtained using three-dimensional reconstructive imaging of a spiral CT scan of the trachea.
Future advances may evolve around optimal tracheal healing and better control of inflammation, fibrosis and granulation tissue formation around the surgical repair site. VEGF and tissue engineering may constitute the major breakthroughs at a cellular level to improve the clinical results and postoperative care after surgical repair of congenital tracheal stenosis.
References
 |
|
  |
 |